ArriVent BioPharma Inc

NAS:AVBPHealthcareCBOEFTSE:MRUTNASDAQ:NBI

$18.85+5.07%At closeAt close · Wed 21 Oct · ≈ AED 69.23 · Market cap $929.45M · Next earnings Mon 9 Nov

Ratio	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Return on equity	−125.2%	−21.2%	−45.8%	−31.2%	−54.1%	−54.1%	+0.0 pts
Return on assets	−119.9%	−20.2%	−42.5%	−29.3%	−49.9%	−49.9%	+0.0 pts
Return on capital employed	−21.1%	−21.2%	−49.2%	−36.6%	−57.8%	—	—
Debt / equity	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	+0.0%
Debt / assets	0.0%	0.1%	0.2%	0.1%	0.0%	—	—
Interest coverage	0.0×	0.0×	0.0×	0.0×	0.0×	—	—
Current ratio	23.6×	21.8×	13.8×	13.1×	12.8×	12.8×	+0.0%
Quick ratio	23.6×	21.8×	13.8×	13.1×	12.8×	—	—
Cash ratio	20.5×	19.5×	12.9×	4.3×	1.8×	1.8×	+0.0%
Asset turnover	0.0×	0.0×	0.0×	0.0×	0.0×	—	—
Receivables turnover	—	—	—	0.0×	0.0×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	—	—

Margins, returns, leverage and liquidityUpdated 31 Dec 2025 ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.